ambroxol has been researched along with Coronary Heart Disease in 1 studies
Ambroxol: A metabolite of BROMHEXINE that stimulates mucociliary action and clears the air passages in the respiratory tract. It is usually administered as the hydrochloride.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In the patients with COPD concurrent with CHD, the combined drug ascoril exerts broncholytic and expectorant effects, with no pronounced negative action on HR." | 2.78 | [The combined drug ascoril in the treatment of patients with chronic obstructive pulmonary disease concurrent with coronary heart disease]. ( Grigor'eva, NIu; Koroleva, ME; Koroleva, TV; Kuznetsov, AN, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Grigor'eva, NIu | 1 |
| Kuznetsov, AN | 1 |
| Koroleva, TV | 1 |
| Koroleva, ME | 1 |
1 trial available for ambroxol and Coronary Heart Disease
| Article | Year |
|---|---|
[The combined drug ascoril in the treatment of patients with chronic obstructive pulmonary disease concurrent with coronary heart disease].
Topics: Adult; Aged; Ambroxol; Antitussive Agents; Comorbidity; Coronary Disease; Dextromethorphan; Expector | 2013 |